Literature DB >> 4823464

The effect of tranquillizing drugs on the concentration of the sulphate ester of 4-hydroxy-3-methoxyphenylethane-1,2-diol in rat brain.

T L Berridge, D F Sharman.   

Abstract

A total of 17 butyrophenone, phenothiazine, benzodiazepine and imidazoline tranquillizing drugs were examined for their ability to increase the cerebral concentration of the sulphate ester of 1(4-hydroxy-3-methoxyphenyl)ethane-1,2-diol (MHPG-SO(3) H), a metabolite of noradrenaline in the rat brain. Of these drugs, when given in a dose of 10 mg/kg i.p., only trifluperidol, haloanisone, azaperone, clozapine and haloperidol were found to increase the cerebral concentration of MHPG-SO(3) H. This effect is unrelated to the ability of such drugs to antagonize the lethal effects of an intravenous injection of noradrenaline and suggests that the properties of the central noradrenaline receptors differ from those of the peripheral noradrenaline receptors.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4823464      PMCID: PMC1776572          DOI: 10.1111/j.1476-5381.1974.tb09604.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  10 in total

1.  EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

Authors:  A CARLSSON; M LINDQVIST
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1963

2.  IS IT POSSIBLE TO PREDICT THE CLINICAL EFFECTS OF NEUROLEPTIC DRUGS (MAJOR TRANQUILLIZERS) FROM ANIMAL DATA?I. "NEUROLEPTIC ACTIVITY SPECTRA" FOR RATS.

Authors:  P A JANSSEN; C J NIEMEGEERS; K H SCHELLEKENS
Journal:  Arzneimittelforschung       Date:  1965-02

3.  MODIFICATION BY DRUGS OF THE METABOLISM OF 3,4-DIHYDROXYPHENYLETHYLAMINE, NORADRENALINE AND 5-HYDROXYTRYPTAMINE IN THE BRAIN.

Authors:  R LAVERTY; D F SHARMAN
Journal:  Br J Pharmacol Chemother       Date:  1965-06

4.  Decrease in homovanillic acid as evidence for dopamine receptor stimulation by apomorphine in the neostriatum of the rat.

Authors:  B E Roos
Journal:  J Pharm Pharmacol       Date:  1969-04       Impact factor: 3.765

5.  Effect of neuroleptic drugs on central catecholamine turnover assessed using tyrosine- and dopamine- -hydroxylase inhibitors.

Authors:  N E Andén; H Corrodi; K Fuxe
Journal:  J Pharm Pharmacol       Date:  1972-03       Impact factor: 3.765

6.  Increase of 3-methoxy-4-hydroxyphenylethylene glycol in rat brain by neuroleptic drugs.

Authors:  H H Keller; G Bartholini; A Pletscher
Journal:  Eur J Pharmacol       Date:  1973-08       Impact factor: 4.432

7.  The rate of formation of 3-methoxy-4-hydroxyphenylethyleneglycol sulfate in brain as an estimate of the rate of formation of norepinephrine.

Authors:  J L Meek; N H Neff
Journal:  J Pharmacol Exp Ther       Date:  1973-03       Impact factor: 4.030

8.  Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data? IV. An improved experimental design for measuring the inhibitory effects of neuroleptic drugs on amphetamine-or apomorphine-induced "Cheroing" and "agitation" in rats.

Authors:  P A Janssen; C J Niemegeers; K H Schellekens; F M Lenaerts
Journal:  Arzneimittelforschung       Date:  1967-07

9.  Receptor activity and turnover of dopamine and noradrenaline after neuroleptics.

Authors:  N E Andén; S G Butcher; H Corrodi; K Fuxe; U Ungerstedt
Journal:  Eur J Pharmacol       Date:  1970       Impact factor: 4.432

10.  Fluorometric estimation of 4-hydroxy-3-methoxyphenylethyleneglycol sulphate in brain.

Authors:  J L Meek; N H Neff
Journal:  Br J Pharmacol       Date:  1972-07       Impact factor: 8.739

  10 in total
  3 in total

1.  Central levels of noradrenaline, 3-methoxy-4-hydroxyphenylethyleneglycol and cyclic AMP in the rat after activation of locus coeruleus neurons: influence of single and repeated neuroleptic treatment.

Authors:  J P Adèr; J B Sebens; J Korf
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

2.  3-Methoxy-4-hydroxyphenylglycol excretion in acutely schizophrenic patients during a controlled clinical trial of the isomers of flupenthixol.

Authors:  M H Joseph; H F Baker; E C Johnstone; T J Crow
Journal:  Psychopharmacology (Berl)       Date:  1979-06-28       Impact factor: 4.530

3.  Evidence for a noradrenergic mechanism in the grooming produced by (+)-amphetamine and 4, alpha-dimethyl-m-tyramine (H 77/77) in rats.

Authors:  J B Lassen
Journal:  Psychopharmacology (Berl)       Date:  1977-10-20       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.